PUMA BIOTECHNOLOGY, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 270.50 thousand shares for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-11.
Discontinued › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2015-05-11
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2015-03-31 was 270.50K shares, a 42.52% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2014-12-31 was 768.63K shares, a 44.23% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2014-09-30 was 405.00K shares, a 138.59% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2014-06-30 was 335.96K shares, a 271.33% increase year-over-year.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2014 was 1.98M shares, a 91.81% increase from fiscal 2013.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2013 was 1.03M shares, a 19.22% decline from fiscal 2012.
- PUMA BIOTECHNOLOGY, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2012 was 1.28M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month |
|---|---|---|---|---|
| 2015-03-31 | 270.50K shares 10-Q · filed 2015-05-11 | 1.04M shares derived: sum of 2 quarters · filed 2015-05-11 | 1.44M shares derived: sum of 3 quarters · filed 2015-05-11 | 1.78M shares derived: sum of 4 quarters · filed 2015-05-11 |
| 2014-12-31 | 768.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | 1.17M shares derived: sum of 2 quarters · filed 2015-03-02 | 1.51M shares derived: sum of 3 quarters · filed 2015-03-02 | 1.98M shares 10-K · filed 2015-03-02 |
| 2014-09-30 | 405.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | 740.96K shares derived: sum of 2 quarters · filed 2014-11-10 | 1.21M shares 10-Q · filed 2014-11-10 | 1.74M shares derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-06-30 | 335.96K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | 806.58K shares 10-Q · filed 2014-08-11 | 1.34M shares derived: sum of 3 quarters · filed 2015-03-02 | 1.51M shares derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-03-31 | 470.63K shares 10-Q · filed 2014-05-12 | 1.00M shares derived: sum of 2 quarters · filed 2015-03-02 | 1.17M shares derived: sum of 3 quarters · filed 2015-03-02 | 1.26M shares derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-12-31 | 532.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | 702.65K shares derived: sum of 2 quarters · filed 2015-03-02 | 793.13K shares derived: sum of 3 quarters · filed 2015-03-02 | 1.03M shares 10-K · filed 2015-03-02 |
| 2013-09-30 | 169.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 260.23K shares derived: sum of 2 quarters · filed 2013-11-12 | 499.48K shares 10-Q · filed 2013-11-12 | |
| 2013-06-30 | 90.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | 329.73K shares 10-Q · filed 2013-08-06 | ||
| 2013-03-31 | 239.25K shares 10-Q · filed 2013-05-09 | |||
| 2012-12-31 | 1.28M shares 10-K · filed 2015-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |